RYMPHYSIA
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RYMPHYSIA, covering 2023-05-06 to 2023-05-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-Emphysema [Phase 4]